MultiHance for dynamic MR imaging of the breast

European Radiology, Supplement

Volumn 14, Issue 7, 2004, Pages

  Sardanelli, Francesco ^a  

^a IRCCS POLICLINICO SAN DONATO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; GADOBENATE DIMEGLUMINE; GADOLINIUM PENTETATE;

ARTICLE; BREAST CANCER; BREAST FIBROADENOMA; BREAST PROSTHESIS; BREAST SURGERY; BREAST TUMOR; CANCER SCREENING; CANCER STAGING; CLINICAL EXAMINATION; CLINICAL PROTOCOL; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; ECHOGRAPHY; GENE MUTATION; HUMAN; IMAGE ANALYSIS; IMAGE PROCESSING; IMAGE QUALITY; LYMPH NODE METASTASIS; MAMMOGRAPHY; MENSTRUAL CYCLE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

BREAST; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CONTRAST MEDIA; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GADOLINIUM DTPA; HUMANS; MAGNETIC RESONANCE IMAGING; MEGLUMINE; OBSERVER VARIATION; ORGANOMETALLIC COMPOUNDS; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY;

EID: 4544377917     PISSN: 16133749     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10406-004-0066-5     Document Type: Article

References (27)

1. Heywang-Kobrunner SH, Beck R (1995) Contrast-enhanced MRI of the breast. 2nd ed. Springer-Verlag, Berlin
2. Heywang SH, Hahn D, Schmidt H, et al (1986) MRI of the breast using gadolinium-DTPA. J Comput Assist Tomogr 10:199-204
3. Sardanelli F, Iozzelli A, Fausto A (2003) Breast MR: indications, established technique and new directions. Eur Radiol 13(Suppl 3):N28-N36
4. Fausto A, Iozzelli A, Steffano GB, Sardanelli F (2004) Fast-STIR as predynamic sequence in breast MR. 10th European Congress of Radiology. Eur Radiol 14 (Suppl 2):284
5. Sardanelli F, Fausto A, Iozzelli A, Rescinito G, Calabrese M (2004) Dynamic breast magnetic resonance imaging: effect of changing the region of interest on early enhancement using 2D and 3D techniques. J Comput Assist Tomogr (in press)
6. Fischer U, Kopka L, Grabbe E (1999) Breast carcinoma: effect of preoperative contrast-enhanced MR imaging on the therapeutic approach. Radiology 213(3):881-888
7. Baum F, Fischer U, Vosshenrich R, Grabbe E (2002) Classification of hypervascularized lesions in CE MR imaging of the breast. Eur Radiol 12(5):1087-1092
8. 3) MR dynamic imaging and single-voxel proton spectroscopy of the breast. An effective way to present morphology, dynamics, and metabolism of breast lesions. Eur Radiol 14 (Suppl 2):382
9. O'Toole M, Caskey CI (2000) Imaging spectrum of breast implant complications: mammography, ultrasound, and magnetic resonance imaging. Semin Ultrasound CT MR 21:351-361
10. Sardanelli F, Giuseppetti GM, Panizza P, et al (2004). Sensitivity of MR versus mammography for detecting foci of multifocal/multicentric breast cancer in fatty and dense breasts using the whole breast pathologic examination as a standard of truth. Am J Roentgenol (in press)
11. Frei KA, Kinkel K, Bonel HM, Lu Y, Esserman LJ, Hylton NM (2000) MR imaging of the breast in patients with positive margins after lumpectomy: influence of the time interval between lumpectomy and MR imaging. Am J Roentgenol 175:1577-1584
12. Muuller RD, Barkhausen J, Sauerwein W, Langer R (1998) Assessment of local recurrence after breast-conserving therapy with MRI. J Comput Assist Tomogr 22:408-412
13. Iozzelli A, Calabrese M, Sardanelli F, et al (2002) MR imaging of the breast in women with prostheses: our model of screening for the evaluation of mammary gland and implant integrity. Radiology 225 (P):112
14. Partridge SC, Gibbs JE, Lu Y, Esserman LJ, Sudilovsky D, Hylton NM (2002) Accuracy of MR imaging for revealing residual breast cancer in patients who have undergone neoadjuvant chemotherapy. Am J Roentgenol 179:1193-1199
15. Schorn C, Fischer U, Luftner-Nagel S, Westerhof JP, Grabbe E (1999) MRI of the breast in patients with metastatic disease of unknown primary. Eur Radiol 9:470-473
16. Kuhl CK, Schmutzler RK, Leutner CC, et al (2000) Breast MR imaging screening in 192 women proved or suspected to be carriers of a breast cancer susceptibility gene: preliminary results. Radiology 215:267-279
17. Podo F, Sardanelli F, Canese R, D'Agnolo G, Natali PG, et al (2002) The Italian multi-centre Project on evaluation of MRI and other imaging modalities in early detection of breast cancer in subjects at high genetic risk. J Exp Clin Canc Res 21(suppl):115-124
18. Sardanelli F, Iozzelli A, Fausto A (2002) Contrast agents and temporal resolution in breast MR imaging. J Exp Clin Cancer Res 21(suppl): 69-75
19. Daldrup-Link HE, Brasch RC (2003) Macromolecular contrast agents for MR mammography: current status. Eur Radiol 13:354-365
20. Spinazzi A, Lorusso V, Pirovano G, Kirchin M (1999) Safety, tolerance, biodistribution and MR imaging enhancement of the liver with gadobenate dimeglumine. Acad Radiol 6:282-291
21. Kirchin MA, Pirovano G, Spinazzi A (1998) Gadobenate dimeglumine (Gd-BOPTA): an overview. Invest Radiol 33:798-809
22. Cavagna FM, Maggioni F, Castelli PM, et al (1997) Gadolinium chelates with weak binding to serum proteins. A new class of high-efficiency, general purpose contrast agents for magnetic resonance imaging. Invest Radiol 32:780-796
23. Knopp MV, Bourne MW, Sardanelli F et al. (2003) Gadobenate dimeglumine-enhanced MRI of the breast: analysis of dose response and comparison with gadopentetate dimeglumine. Am J Roentgenol 181:663-678
24. Sardanelli F, Fausto A, Kirchin M (2004) Gadobenate dimeglumine (Gd-BOPTA) as a contrast agent for dynamic breast MR: effect of a higher initial enhancement threshold on the diagnostic performance. Eur Radiol 14 (Suppl 2): 285
25. Sardanelli F, Iozzelli A, Aliprandi A, Salerio I (2002) Breast vascular maps with Gd-enhanced MR imaging using different doses of Gd-BOPTA. Eur Radiol 12 (Suppl 1): 159.
26. Sardanelli F, Iozzelli A, Fausto A, Carriero A, Kirchin M. Breast vascular mapping with gadobenate dimeglumine (Gd-BOPTA): association between cancer and ipsilateral increased vasculature. Radiology (in press)
27. Sardanelli F, Iozzelli A, Aliprandi A, Salerio I (2002) Asymmetry of vascular maps obtained by Gd-BOPTA-enhanced breast MR-predictive for breast cancer? Eur Radiol 12 (Suppl 1):159